ECB Rate Hikes Could Be Big Mistake Amid Stagflation Risks Berenberg Economist Warns Singtel Share Decline Analysts Support Digital Infrastructure Strategy PNC Infratech Gains Brokerage Optimism Potential 46 Upside Projected After Q4 Results Ashok Leyland Q4 Results Company Posts Record PAT of 1405 Crore Declares 250 Dividend PutinXi Talks to Revive Stalled Power of Siberia 2 Gas Pipeline Amid Iran Conflict New York Fed Study Reveals Gas Price Surge Disproportionately Impacts LowerIncome Households MDA Space Q1 2026 Earnings EPS Beat Drives Positive Market Reaction Bank OZK OZK Q1 2026 Earnings Modest EPS Miss Amid Stable Operations TS Q1 2026 Earnings EPS Surpasses Estimates But Stock Slips Amid Uncertain Revenue Outlook WHLRP Q2 2024 Earnings Positive EPS Surprise Amid Steep Stock Decline MRLN Q1 2026 Earnings Record EPS Surge Driven by Cost Controls Though Revenue Details Remain Unclear Annexon Inc ANNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline but No Revenue Yet USA TODAY Co Inc TDAY Holds Steady at 756 as Traders Eye Key Support and Resistance Levels Akebia Therapeutics AKBA Edges Higher at 104 Key Levels in Focus Nuveen New York Municipal Value Fund NNY Posts Modest Uptick Amid Stable Trading Tectonic Therapeutic TECX Gains 21 as Stock Approaches Key Resistance at 3058 Lionheart Holdings Unit CUBWU Holds Steady at 1085 as Market Awaits Catalyst LCID Q1 2026 Earnings EPS Misses Estimates Amidst Production Challenges MBX Q1 2026 Earnings Narrower Than Expected Loss as Clinical Progress Continues Brookfield Renewable Partners Q1 2026 Earnings Widely Missed EPS Estimates as Operating Challenges Persist Customers Bancorp Inc Q1 2026 Earnings EPS Beats Estimates Amidst Challenging Banking Environment PFXNZ Q1 2026 Earnings Strong EPS Beat Driven by Solid Investment Income PEPG Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Walmart WMT Gains Hedge Fund Attention Amid Mixed Analyst Outlooks PRDO Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Despite Opaque Revenue Picture Oncolytics Biotech ONCY Stages an 11 Rally as Biotech Momentum Builds